Common use of Royalties on Net Sales of Products Clause in Contracts

Royalties on Net Sales of Products. During the Royalty Term applicable to each Product, and subject to adjustment as set forth in Section 4.2(b), Ikaria shall pay to BioLineRx royalties on a Product-by-Product basis, with the amount of such royalties calculated as a percentage of Net Sales in a calendar year for such Product as set forth below: Net Sales Royalty Up to $[**] [**] % >$[**] to $[**] [**] % >$[**] [**] %

Appears in 4 contracts

Samples: License and Commercialization Agreement (Bellerophon Therapeutics LLC), License and Commercialization Agreement (Bellerophon Therapeutics LLC), License and Commercialization Agreement (Ikaria, Inc.)

AutoNDA by SimpleDocs

Royalties on Net Sales of Products. During the Royalty Term applicable to each Product, and subject to adjustment as set forth in Section 4.2(b), Ikaria shall pay to BioLineRx royalties on a Product-by-Product basis, with the amount of such royalties calculated as a percentage of Net Sales in a calendar year for such Product as set forth below: Net Sales Royalty Up to $[***] [**] % >$[**] to $[**] [**] % >$[**] [**] %]

Appears in 2 contracts

Samples: License and Commercialization Agreement (BioLineRx Ltd.), License and Commercialization Agreement (BioLineRx Ltd.)

Royalties on Net Sales of Products. During the Royalty Term applicable to each Product, and subject to adjustment as set forth in Section 4.2(b), Ikaria shall pay to BioLineRx royalties on a Product-by-Product basis, with the amount of such royalties calculated as a percentage of Net Sales in a calendar year for such Product as set forth below: Net Sales Royalty Up to $[**] [**] 250 Million 11 % >$[**] 250 Million to $[**] [**] 1 Billion 13 % >$[**] [**] 1 Billion 15 %

Appears in 1 contract

Samples: License and Commercialization Agreement (Bellerophon Therapeutics, Inc.)

AutoNDA by SimpleDocs

Royalties on Net Sales of Products. During the Royalty Term applicable to each Product, and subject to adjustment as set forth in Section 4.2(b), Ikaria shall pay to BioLineRx royalties on a Product-by-Product basis, with the amount of such royalties calculated as a percentage of Net Sales in a calendar year for such Product as set forth below: Net Sales Royalty Up to $[***] [**] % >$[**] to $[**] [**] % >$[**] [**] %]

Appears in 1 contract

Samples: License and Commercialization Agreement (BioLineRx Ltd.)

Time is Money Join Law Insider Premium to draft better contracts faster.